Task: Answer the multiple choice question.
Question: Which drug exhibits a -61.984% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CCC(C(=O)NC1CC1)n1nc(C)c2c(C)n(-c3ccc(C)cc3)nc2c1=O
b: O=C(c1cc(F)ccc1F)C1CCCN(C(=O)c2ccc3nccnc3c2)C1
Answer: a. CCC(C(=O)NC1CC1)n1nc(C)c2c(C)n(-c3ccc(C)cc3)nc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C(=O)NC1CC1)n1nc(C)c2c(C)n(-c3ccc(C)cc3)nc2c1=O
CCC(C(=O)NC1CC1)n1nc(C)c2c(C)n(-c3ccc(C)cc3)nc2c1=O
N-cyclopropyl-2-[3,4-dimethyl-2-(4-methylphenyl)-7-oxopyrazolo[3,4-d]pyridazin-6-yl]butanamide